Mike Cooke
Signal active
Co-Founder and Chief Executive Officer
Contact Information
Social
Primary Organization
AmacaThera
Founded
2016
Employees
1-10
Industry
Biotechnology, Biopharma, Therapeutics
Bio
Mike Cooke joined Molly's laboratory in 2008 as a post-doctoral fellow to work on stem cell transplantation for recovery following stroke. This resulted in a co-first author publication in Stem Cell Reports demonstrating cells combined with HAMC could restore stroke injury in a model of stroke.
Together with Molly, Mike developed the first product for AmacaThera, a sustained analgesic for post-operative pain. This product is nearing completion of pre-clinical studies and IND enabling studies will commence in 2018. Mike pitched to both UTEST and OBIO, securing dilutive and non-dilutive seed investment for AmacaThera.
Location
Toronto, Ontario, Canada, North America
Board and Advisor Roles
0
N/A
Educations
1
N/A
Profile Resume
Mike Cooke is the Co-Founder and Chief Executive Officer at AmacaThera, based in North America. With a background in Biotechnology, Mike Cooke has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity